Search results
The 1 Phrase You Should Never, Ever Say To A Toddler
HuffPost Life via Yahoo News· 3 hours ago“As they grow, they have more ideas of their own, what they want and don’t want. That includes...to a “Fine, I’m leaving without you then.” It may help...
Amgen shares target raised by Mizuho despite Amgen Phase 2 uncertainty By Investing.com
Investing.com· 7 days agoThe firm kept its rating unchanged while adjusting the target. This adjustment comes despite...
Earnings call: Lumos Pharma gears up for Phase 3 trial of LUM-201 By Investing.com
Investing.com· 12 hours agoLumos Pharma (NASDAQ:LUMO), a biopharmaceutical company, detailed their progression towards a Phase...
Acurx Pharmaceuticals Inc (ACXP) Q1 2024 Earnings Call Transcript Highlights: Key Financial and ...
GuruFocus.com via Yahoo Finance· 3 hours agoPositive Points Ibezapolstat showed superior efficacy in eradicating C. difficile compared to vancomycin in Phase IIb trials, with a 94% success rate versus 71% for vancomycin ...
Bitcoin encounters $60k resistance amid market uncertainty
CryptoNewsZ.com· 19 hours agoBitcoin’s consolidation phase is not a new phenomenon. If anything, it is giving the market a sense...
Q1 2024 ICAD Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 49 minutes agoThese forward-looking statements are based on current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from these ...
Omeros Corp (OMER) Q1 2024 Earnings Call Transcript Highlights: Financial Shifts and Strategic ...
GuruFocus.com via Yahoo Finance· 3 hours agoOMS1029 has successfully completed a Phase 1 study, supporting once quarterly dosing, and is moving towards Phase 2 trials in potential large-value indications ...
Q3 2024 Palatin Technologies Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 hours agoAll coming from our highly productive research activities. Now for our PL9643 dry eye disease program, we reported the positive Phase 3 MELODY-1 results earlier in the quarter ...
Q1 2024 Acurx Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 hours agoIn January, we announced positive comparative microbiology and microbiome data for ibezapolstat, our lead antibiotic candidate in C. diff patients from the Phase IIb clinical ...
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical...
Morningstar· 21 hours agoAtossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer. The Karisma-Endoxifen ...
